State Street Portfolio holdings
State Street Corporation, established in 1792 and headquartered in Boston, Massachusetts, is one of the oldest financial institutions in the United States and a major player in the global asset management and custody banking sectors. Primarily known for its custodial services, it safeguards assets for institutional investors, managing trillions of dollars through its State Street Global Advisors (SSGA) division, which is renowned for launching the first U.S. exchange-traded fund (ETF), the SPDR S&P 500 ETF (SPY), in 1993. The company provides a range of services including investment management, research, trading, and data analytics, catering mostly to institutional clients like pension funds, endowments, and mutual funds. With a focus on financial infrastructure and innovation, State Street has positioned itself as a key backbone in the global investment ecosystem.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$3.42B |
| 2 |
Cigna
CI
|
+$1.25B |
| 3 |
CVS Health
CVS
|
+$1.25B |
| 4 |
Marathon Petroleum
MPC
|
+$805M |
| 5 |
Diamondback Energy
FANG
|
+$589M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$3.86B |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$2.31B |
| 3 |
PX
Praxair Inc
PX
|
+$2.1B |
| 4 |
Apple
AAPL
|
+$1.38B |
| 5 |
ANDV
Andeavor
ANDV
|
+$1.1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.79% |
| 2 | Technology | 15.42% |
| 3 | Healthcare | 14.78% |
| 4 | Industrials | 11.06% |
| 5 | Consumer Discretionary | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LOVE
3226
LoveSac
LOVE
$276M
| $1.01M | ﹤0.01% |
+44,111
| New | +$914K |
|
|
ALNA
3227
DELISTED
Allena Pharmaceuticals
ALNA
| $1.01M | ﹤0.01% |
185,307
+387
| +0.2% | +$3.34K |
|
|
EIDX
3228
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $1.01M | ﹤0.01% |
73,147
+46,547
| +175% | +$587K |
|
|
CWBR
3229
DELISTED
CohBar, Inc. Common Stock
CWBR
| $1M | ﹤0.01% |
10,765
+313
| +3% | +$34.8K |
|
3230
Replimune Group
REPL
$986M
| $994K | ﹤0.01% |
99,381
+23,900
| +32% | +$323K |
|
3231
KALA BIO
KALA
$14.8M
| $993K | ﹤0.01% |
81
+3
| +4% | +$52K |
|
|
SVA
3232
DELISTED
Sinovac Biotech, Ltd
SVA
| $982K | ﹤0.01% |
141,512
+18,791
| +15% | +$137K |
|
|
RJET
3233
Republic Airways Holdings
RJET
$1.03B
| $981K | ﹤0.01% |
8,483
+3,143
| +59% | +$582K |
|
3234
Syndax Pharmaceuticals
SNDX
$1.71B
| $973K | ﹤0.01% |
218,652
+22,794
| +12% | +$125K |
|
|
KA
3235
DELISTED
Kineta, Inc. Common Stock
KA
| $970K | ﹤0.01% |
2,138
+213
| +11% | +$144K |
|
3236
Gold Fields
GFI
$33.6B
| $966K | ﹤0.01% |
274,570
-12,346
| -4% | -$36.4K |
|
3237
Comscore
SCOR
$111M
| $957K | ﹤0.01% |
3,315
+1,998
| +152% | +$645K |
|
3238
STMicroelectronics
STM
$47.4B
| $951K | ﹤0.01% |
68,500
-36,611
| -35% | -$549K |
|
|
LXFT
3239
DELISTED
Luxoft Holding, Inc.
LXFT
| $950K | ﹤0.01% |
31,222
+937
| +3% | +$35K |
|
|
GRTS
3240
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $945K | ﹤0.01% |
+61,160
| New | +$1.17M |
|
3241
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.76B
| $937K | ﹤0.01% |
35,995
-26,185
| -42% | -$703K |
|
3242
Spero Therapeutics
SPRO
$72.4M
| $935K | ﹤0.01% |
152,093
+24,168
| +19% | +$196K |
|
3243
iShares Core MSCI EAFE ETF
IEFA
$194B
| $932K | ﹤0.01% |
16,952
+91
| +0.5% | +$5.34K |
|
3244
Lesaka Technologies
LSAK
$411M
| $926K | ﹤0.01% |
197,547
+16,196
| +9% | +$95.1K |
|
|
LLEX
3245
DELISTED
Lilis Energy, Inc. Common Stock
LLEX
| $924K | ﹤0.01% |
674,778
-25,395
| -4% | -$68.8K |
|
|
NEOS
3246
DELISTED
Neos Therapeutics, Inc
NEOS
| $918K | ﹤0.01% |
556,267
+97,846
| +21% | +$275K |
|
3247
Travelzoo
TZOO
$74.9M
| $917K | ﹤0.01% |
93,285
+4,182
| +5% | +$39.3K |
|
3248
Vanguard Total World Stock ETF
VT
$79.6B
| $912K | ﹤0.01% |
13,933
-12
| -0.1% | -$840 |
|
|
VIA
3249
DELISTED
Viacom Inc. Class A
VIA
| $907K | ﹤0.01% |
32,408
+2,150
| +7% | +$73.3K |
|
3250
Arvinas
ARVN
$539M
| $903K | ﹤0.01% |
+70,249
| New | +$1.11M |
|
Similar funds
State Street's Q4 2018 Portfolio in Review
As of Q4 2018, State Street held 3,872 positions worth $1.1T, down 16% from $1.3T the previous quarter. Its ten largest holdings account for 17% of the portfolio.
State Street's Q4 2018 filing shows 102 new, 1,442 increased, 2,108 reduced and 110 closed positions. Its largest new stake was Linde: 21,625,224 shares worth $3.37B. The largest sale was Aetna Inc, an estimated $3.86B.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 16% a quarter earlier, followed by Technology and Healthcare.
- State Street's largest Q4 2018 buy was Linde: 21,625,224 shares worth $3.37B.
- State Street added most to Cigna in Q4 2018, an estimated $1.25B increase.
- State Street's biggest Q4 2018 reduction was Apple, cutting an estimated $1.38B.
- State Street fully exited Aetna Inc in Q4 2018, selling an estimated $3.86B.
- State Street's ten largest holdings make up 17% of its $1.1T portfolio in Q4 2018.
- State Street opened 102 new positions and closed 110 in Q4 2018.
- State Street's portfolio value fell 16% quarter-over-quarter to $1.1T.
Based on State Street's 13F filing for Q4 2018, filed 12 Feb 2019.